Levetiracetam for Treatment of Pain Associated With Fibromyalgia

Summary

The purpose of this study is to assess the safety and effectiveness of levetiracetam in reducing the pain of fibromyalgia when compared to placebo. Levetiracetam, an anti-seizure drug, is currently FDA-approved and marketed for use in patients with seizures. Levetiracetam may relieve pain by reducing abnormal activity in the nervous system. A placebo is an inactive substance.

Timeline

Start

2004-03

Primary completion

2005-03

Completion

2005-04

Drugs

Indications